ROVI updates its strategy in a meeting with shareholders, investors and analysts
Tue, 16/11/2021 - 14:31
1 minROVI updates its strategy in a meeting with shareholders, investors and analysts
Related
Madrid, 27 March 2023
Laboratorios Farmacéuticos ROVI and ReTree are collaborating to plant ROVI’s Forest in the Madrid Sierra. It is an...
3 min
27/03/2023
Madrid, 21 March 2023
Laboratorios Farmacéuticos ROVI announces its incorporation as a member of the General Assembly of the Spanish...
3 min
21/03/2023
ROVI REPORTS OPERATING REVENUE GROWTH OF 26% AND EBITDA GROWTH OF 37%
Operating revenue increased by 26% to 817.7 million euros...
3 min
21/02/2023
shutterstock_1323088832.jpg
TO THE SPANISH NATIONAL SECURITIES MARKET COMMISSION
(COMISIÓN NACIONAL DEL MERCADO DE VALORES)
Madrid, 16 November 2021
In compliance with the reporting requirements provided for in article 227 of the consolidated text of the Securities Market Act, ROVI sends and publishes the attached presentation regarding the update of the company strategy, a presentation that will be distributed today and which can be accessed through the website of the company. Likewise, ROVI will hold a virtual meeting today with analysts and investors to present said presentation.
Mr. Juan López-Belmonte Encina
Chairman and Chief Executive Officer
Laboratorios Farmacéuticos ROVI, S.A.